HB3498, the Henrietta Lacks Congressional Gold Medal Act, would award Henrietta Lacks a posthumous Congressional Gold Medal in recognition of the extraordinary scientific and medical contributions associated with her immortal HeLa cell line. The bill recounts Lacks’ life, her treatment at Johns Hopkins Hospital in 1951, the unauthorized taking of tumor cells, and the subsequent creation of the first known immortal human cell line. It emphasizes that HeLa cells have been central to major advances in medicine and biology, including the polio vaccine, cancer research, HIV/AIDS treatment, gene mapping, precision medicine, and studies of radiation and zero gravity.
The measure directs the Speaker of the House and the President pro tempore of the Senate to arrange for the medal’s presentation, and it authorizes the Secretary of the Treasury to design and strike the medal. After presentation, the medal would be transferred to the Smithsonian Institution for display and research, with a sense-of-Congress statement encouraging display at locations associated with Henrietta Lacks. The bill also allows the Treasury to strike and sell duplicate bronze medals, treats the medals as national medals and numismatic items under federal law, and uses the United States Mint Public Enterprise Fund to cover costs and receive proceeds from duplicate sales.
The bill’s legal impact is limited and largely symbolic, as it does not change substantive health, research, or civil rights law. Its main effect is to create a federal honor and establish administrative authority for the Mint and Smithsonian to produce, hold, and potentially display the medal. It also reinforces the federal recognition of Henrietta Lacks’ role in biomedical research and the broader history of informed consent and bioethics.
General sentiment around the bill is strongly positive and commemorative. The findings frame Lacks as a foundational figure in modern science and a symbol of both scientific progress and the ethical lessons of medical research. Because there are no recorded committee transcripts or votes in the provided material, there is no evidence of organized opposition or debate in the available record.
Notable points of contention are minimal in the text itself, but the bill’s findings highlight the historically controversial fact that Lacks’ cells were taken without her consent. That issue is presented as part of the reason her legacy matters to bioethics and informed consent law, rather than as a live dispute over the bill. The only practical questions raised by the legislation concern medal design, Smithsonian placement, and the use of Mint funds, all of which appear routine and noncontroversial.
HB3498 would add a new federal commemorative medal honoring Henrietta Lacks and would authorize the Treasury Department and U.S. Mint to design, strike, and distribute the medal, with the original going to the Smithsonian Institution. It would not amend existing health, research, or consent statutes, but it would operate within federal law governing national medals, numismatic items, and the Mint Public Enterprise Fund. The bill primarily affects federal commemorative practices and the institutions responsible for producing and displaying the medal.
The overall sentiment is highly favorable and celebratory. The bill presents Henrietta Lacks as a landmark figure in medical science and patient rights, and the sponsor list suggests broad bipartisan and cross-caucus support. With no committee transcript or vote record provided, there is no indication of substantive opposition in the available materials.
There is little visible contention in the bill or the available context. The only potentially sensitive issue is the underlying history that HeLa cells were taken without Henrietta Lacks’ consent, which the bill acknowledges as part of her bioethical legacy. Any practical discussion would likely center on commemorative details such as medal design, Smithsonian placement, and funding through the Mint, rather than on the merits of honoring Lacks.